Action A246960 SCL SCIENCE INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues SCL Science Inc.

Actions

A246960

KR7246960009

Cours en clôture Korea S.E.
Autres places de cotation
 00:00:00 03/05/2024 		Varia. 5j. Varia. 1 janv.
8 730 KRW +0,69% Graphique intraday de SCL Science Inc. -0,80% -1,58%
2023 Lee Moon Su a finalisé l'acquisition d'une participation de 98,04% dans NVC 2019 Bio Health Care Investment Association auprès d'InnoTherapy, Inc. (KOSDAQ:A246960). CI
2022 SCL Healthcare Co., Ltd. a finalisé l'acquisition d'une participation de 22,97% dans InnoTherapy, Inc. (KOSDAQ:A246960) auprès de Lee, Moon Soo. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
H2U Corp. announced that it has received KRW 1.29506497 billion in funding from InnoTherapy, Inc.
H2U Corp. announced that it has received KRW 1.2171 billion in funding from InnoTherapy, Inc.
InnoTherapy, Inc. announced that it has received KRW 5.9999961 billion in funding from Scl Holdings and another investor
Health to U Corporation announced that it has received funding from InnoTherapy, Inc.
H2U Corp. announced that it expects to receive KRW 1.2171 billion in funding from InnoTherapy, Inc.
InnoTherapy, Inc. announced that it expects to receive KRW 5.9999961 billion in funding
PhAST Corp. announced that it has received KRW 1.30609774 billion in funding from InnoTherapy, Inc.
Lee Moon Su completed the acquisition of a 98.04% stake in NVC 2019 Bio Health Care Investment Association from InnoTherapy, Inc.
Lee Moon Su agreed to acquire 98.039216% stake in NVC 2019 Bio Health Care Investment Association from InnoTherapy, Inc. for approximately KRW5 billion.
PhAST Corp. announced that it expects to receive KRW 1.30609774 billion in funding from InnoTherapy, Inc.
InnoTherapy, Inc. announced that it has received KRW 4.999995 billion in funding from SCL Healthcare Co., Ltd., Seoul Clinical Laboratories
InnoTherapy, Inc. announced that it expects to receive KRW 4.999995 billion in funding from SCL Healthcare Co., Ltd., Seoul Clinical Laboratories
SCL Healthcare Co., Ltd. completed the acquisition of 22.97% stake in InnoTherapy, Inc. from Lee, Moon Soo.
SCL Healthcare Co., Ltd. agreed to acquire 22.97% stake in InnoTherapy, Inc. from Lee, Moon Soo for KRW 21.8 billion.
InnoTherapy, Inc. announced that it has received KRW 14.999868397 billion in funding from a group of investors
InnoTherapy, Inc. announced that it expects to receive KRW 7.5 billion in funding from Samsung Securities Co. Ltd., Investment Arm, KB Securities Co., Ltd., Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, His-Story Investment Co.,Ltd., Shinhan Bank, Investment Arm, Shinhan Bank, Investment Arm, and Pureun Mutual Savings Bank Co., Ltd and another investor
InnoTherapy, Inc. cancelled the acquisition of 98.04% stake in NVC 2019 Bio Health Care Investment Association.
InnoTherapy, Inc. agreed to acquire 98.04% stake in NVC 2019 Bio Health Care Investment Association for KRW 5 billion.
NVC Partners announced that it has received KRW 1.1 billion in funding from InnoTherapy, Inc.
InnoTherapy, Inc. has completed an IPO in the amount of KRW 9 billion.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action A246960
  4. Actualités SCL Science Inc.
  5. Autres langues